Key result
AF in cancer patients complicates therapy due to limited evidence for CHA2DS2-VASc and HAS-BLED scores.
Why the study?
AF is more common in patients with malignancies, but a paucity of evidence and limited validation of standard risk scores complicate therapeutic management in this high-risk population.
This review highlights the complex pathophysiological link between atrial fibrillation and cancer, emphasizing the need for tailored anticoagulation management due to the high risk of both thromboembolic and bleeding events.
Demands individualized anticoagulation decisions amid elevated risks; leaves open validation of cancer-specific risk tools in prospective trials.
Atrial fibrillation (AF) is more common in patients with malignancies than in general population. The pathophysiological processes include the pro-inflammatory condition and the exaggerated inflammatory reaction to chemotherapy, radiotherapy, and surgery interventions. Thus, it is pivotal to decrease morbidity and mortality in this group by providing appropriate care and prevention. In this subset, the risk of thromboembolic and bleeding events is high and the common risk score such as CHA2DS2-VASc and HAS-BLED employed in non-oncologic patients have limited evidence in cancer patients. A paucity of evidence in the setting in individuals having both malignancies and atrial fibrillation entangle the clinician when it comes to therapeutic management. Tailored management is recommended of anticoagulation treatment could be difficult, and there is. In this review, we try to explain the mechanism of AF in cancer patients as well as its management in this setting.
No takes yet. Share an insight, caveat, or question.
Nardi et al. (2024) conducted a review in Atrial fibrillation and cancer. Atrial fibrillation in cancer patients presents a therapeutic conundrum due to high thromboembolic and bleeding risks and limited evidence for standard risk scores like CHA2DS2-VASc and HAS-BLED.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: